Hot Topics | Published:

Regulation of raphe serotonin neurons by serotonin 1A and 2B receptors

Neuropsychopharmacologyvolume 44pages218219 (2019) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Richardson-Jones JW, Craige CP, Guiard BP, Stephen A, Metzger KL, Kung HF, et al. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron. 2010;65:40–52.

  2. 2.

    Doly S, Valjent E, Setola V, Callebert J, Herve D, Launay JM, et al. Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro. J Neurosci. 2008;28:2933–40.

  3. 3.

    Diaz SL, Doly S, Narboux-Nême N, Fernandez S, Mazot P, Banas S, et al. 5-HT2B receptors are required for serotonin-selective antidepressant actions. Mol Psychiatry. 2012;17:154–63.

  4. 4.

    Belmer A, Quentin E, Diaz SL, Guiard BP, Fernandez SP, Doly S, et al. Positive regulation of raphe serotonin neurons by serotonin 2B receptors. Neuropsychopharmacology. 2018;43:1623–32.

  5. 5.

    Bevilacqua L, Doly S, Kaprio J, Yuan Q, Tikkanen R, Paunio T, et al. A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature. 2010;468:1061–6.

  6. 6.

    Colgan LA, Cavolo SL, Commons KG, Levitan ES. Action potential-independent and pharmacologically unique vesicular serotonin release from dendrites. J Neurosci. 2012;32:15737–46.

Download references

ACKNOWLEGMENT

This work has been supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Santé et de la Recherche Médicale, the Sorbonne Universités, and by grants from the Fondation pour la Recherche sur le Cerveau, the Fondation de France, the Région Ile-de-France, the Fondation pour la Recherche Médicale "Equipe FRM DEQ2014039529", the French Ministry of Research (Agence Nationale pour la Recherche ANR-17-CE16-0008 and the Investissements d'Avenir programme ANR-11-IDEX-0004-02) and the DIM Cerveau et Pensée région Ile-de-France (PME2012). L.M.'s team is part of the École des Neurosciences de Paris Ile-de-France network and of the Bio-Psy Labex and as such this work was supported by French state funds managed by the ANR within the Investissements d'Avenir programme under reference ANR-11-IDEX-0004-02.

Author information

Affiliations

  1. INSERM U 839, Paris, 75005, France

    • Arnauld Belmer
    •  & Luc Maroteaux
  2. UMR-S839 Sorbonne Université, Paris, 75005, France

    • Arnauld Belmer
    •  & Luc Maroteaux
  3. Institut du Fer à Moulin, Paris, 75005, France

    • Arnauld Belmer
    •  & Luc Maroteaux
  4. Translational Research Institute, Queensland University of Technology, Brisbane, QLD, 4059, Australia

    • Arnauld Belmer

Authors

  1. Search for Arnauld Belmer in:

  2. Search for Luc Maroteaux in:

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to Luc Maroteaux.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41386-018-0214-6